Company profile for Poseida Therapeutics, Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell therapeutics for patients with high unmet medical need. Our mission at Poseida Therapeutics is to create cell therapies with the capacity to cure. We are developing novel products using our broad gene engineering platform technologies, with the goal of bringing new and...
We are a clinical-stage biopharmaceutical company leveraging our proprietary next-generation, non-viral gene engineering technologies to create life-saving cell therapeutics for patients with high unmet medical need. Our mission at Poseida Therapeutics is to create cell therapies with the capacity to cure. We are developing novel products using our broad gene engineering platform technologies, with the goal of bringing new and better treatments to patients with serious diseases, first in the blood-based cancer Multiple Myeloma and eventually in solid tumors like prostate cancer.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
9390 Towne Centre Drive, Suite 200 San Diego, CA 92121
Telephone
Telephone
858.779.3100
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.roche.com/media/releases/med-cor-2025-01-08

PRESS RELEASE
09 Jan 2025

https://www.prnewswire.com/news-releases/poseida-therapeutics-highlights-positive-interim-phase-1-results-for-p-bcma-allo1-and-preclinical-data-for-dual-car-t-p-cd19cd20-allo1-at-the-66th-american-society-of-hematology-ash-annual-meeting-302325606.html

PR NEWSWIRE
09 Dec 2024

https://www.globenewswire.com/news-release/2024/12/09/2994099/0/en/Roche-commences-tender-offer-for-all-shares-of-Poseida-Therapeutics-Inc-for-9-00-per-share-in-cash-plus-a-non-tradeable-contingent-value-right-for-up-to-4-00-per-share-in-cash.html

GLOBENEWSWIRE
09 Dec 2024

https://www.globenewswire.com/news-release/2024/11/26/2987189/0/en/Roche-enters-into-a-definitive-agreement-to-acquire-Poseida-Therapeutics-including-cell-therapy-candidates-and-related-platform-technologies.html

GLOBENEWSWIRE
26 Nov 2024

https://www.prnewswire.com/news-releases/poseida-therapeutics-provides-updates-and-financial-results-for-the-third-quarter-of-2024-302299335.html

PR NEWSWIRE
07 Nov 2024

https://www.prnewswire.com/news-releases/poseida-therapeutics-to-present-new-preclinical-data-supporting-non-viral-gene-editing-with-p-klkb1-101-for-the-treatment-of-hereditary-angioedema-302285382.html

PR NEWSWIRE
24 Oct 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Contact Poseida Therapeutics, Inc and get a quotation

Poseida Therapeutics, Inc is a supplier offers 1 products (APIs, Excipients or Intermediates).

Find a price of Rimiducid bulk with DMF offered by Poseida Therapeutics, Inc

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty